new glp 1 drug retatrutide Unapproved weight loss causes extreme side effects Extreme Side Effects Followed Overdose
Description
In those rare cases of particularly intense and/or persistent GI AEs, HCPs can apply further measures (Figure 4): If GI AEs appear during the dose-escalating phase, HCPs could modify the planned schedule by implementing one or several of the following points [35,36]: Extend the dose escalation phase duration (24 more weeks with the previous dose or temporary suspension)

Retrieved from Wilding, J., Batterham, R

[Accessed on 18.4.2015]

You might recognize other prescription drugs in this group such as Wegovy, Zepbound and Mounjaro

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (736) amide in patients with NIDDM

Physician 102 , 603612 (2020)
